VeriMomHamilelikte cannabigerol kullanmaktan kaçınmalı mıyım? | VeriMom
No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
ECHA regulatory hazard statements
- •H361D
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- cannabigerol hamilelikte güvenli mi?
- No harmonised (Annex VI CLP) reproductive classification for cannabigerol (CBG) was identified; ECHA InfoCard shows company C&L notifications reporting H361d but this appears to come from C&L notifications rather than a legally harmonised CLH entry, and there are no CIR or SCCS safety opinions specific to CBG. Cannabinoids as a class (e.g., THC/CBD) have been associated with developmental effects in animal and human studies, giving a plausible class-based mechanism, but direct reproductive/teratogenic data for CBG are lacking; dermal absorption is plausible and likely low-but-measurable for a small lipophilic phytocannabinoid. (See ECHA InfoCard; PubChem; human/animal cannabinoid developmental reviews.).
- cannabigerol emzirirken güvenli mi?
- There are no authoritative safety assessments (CIR/SCCS/harmonised CLP) specifically identifying CBG as a confirmed reproductive or lactation hazard. Cannabinoids can be transferred to milk (class concern from THC/CBD literature) so a theoretical class-based mechanism exists, but direct studies on CBG transfer in human milk or lactation-specific toxicity are not found; topical cosmetic use would give low but measurable maternal systemic exposure in some scenarios, so breastfeeding exposure is possible but not characterized for CBG.
- cannabigerol bebek cildi için güvenli mi?
- No infant-specific toxicity or safety data for topical CBG were identified. By class-based analogy to other cannabinoids there is a theoretical mechanism, but no direct evidence that CBG causes reproductive/infant toxicity. Because infant skin has higher absorption per kg, exposure score is increased by +1 compared with adults when measurable dermal absorption is plausible; direct dermal absorption studies for CBG were not found.
- VeriMom cannabigerol nasıl puanlıyor?
- VeriMom cannabigerol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 27/100 (yüksek risk) olarak puanlar.
- Hamilelikte cannabigerol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.